ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.795
      0.22%
      Bitcoin
      94,195.49
      -0.31%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Aimia Inc (AIM.PR.A) Quote

      Aimia Inc

      Aimia Inc (AIM.PR.A)

      TSX
      16.35
      0.00
      (0.00%)
      Closed January 13 4:12PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      16.35
      Bid
      16.50
      Ask
      17.39
      Volume
      1,100
      16.35 Day's Range 16.50
      0.00 52 Week Range 0.00
      Market Cap
      1.385B
      Previous Close
      16.35
      Open
      16.50
      Last Trade
      500
      @
      16.35
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      84,694,000
      Dividend Yield
      -
      PE Ratio
      -1.23
      Earnings Per Share (EPS)
      -2.23
      Revenue
      291.2M
      Net Profit
      -188.6M

      About Aimia Inc

      Sector
      Mgmt Invt Offices, Open-end
      Industry
      Mgmt Invt Offices, Open-end
      Website
      www.aimia.com
      Headquarters
      Montreal, Quebec, Can
      Founded
      -
      Aimia Inc is listed in the Mgmt Invt Offices, Open-end sector of the Toronto Stock Exchange with ticker AIM.PR.A. The last closing price for Aimia was $16.35. Over the last year, Aimia shares have traded in a share price range of $ 0.00 to $ 0.00.

      Aimia currently has 84,694,000 shares outstanding. The market capitalization of Aimia is $1.38 billion. Aimia has a price to earnings ratio (PE ratio) of -1.23.

      Ask ADVFN Intelligence (AI)

      AIM.PR.A Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000PR
      40000000PR
      120000000PR
      260000000PR
      520000000PR
      1560000000PR
      2600000000PR

      AIM.PR.A - Frequently Asked Questions (FAQ)

      What is the current Aimia share price?
      The current share price of Aimia is $ 16.35
      How many Aimia shares are in issue?
      Aimia has 84,694,000 shares in issue
      What is the market cap of Aimia?
      The market capitalisation of Aimia is CAD 1.38B
      What is the 1 year trading range for Aimia share price?
      Aimia has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Aimia?
      The price to earnings ratio of Aimia is -1.23
      What is the cash to sales ratio of Aimia?
      The cash to sales ratio of Aimia is 0.8
      What is the reporting currency for Aimia?
      Aimia reports financial results in CAD
      What is the latest annual turnover for Aimia?
      The latest annual turnover of Aimia is CAD 291.2M
      What is the latest annual profit for Aimia?
      The latest annual profit of Aimia is CAD -188.6M
      What is the registered address of Aimia?
      The registered address for Aimia is TOUR AIMIA - 525, VIGER AVENUE WEST, SUITE 1000, MONTREAL, QUEBEC, H2Z 0B2
      What is the Aimia website address?
      The website address for Aimia is www.aimia.com
      Which industry sector does Aimia operate in?
      Aimia operates in the MGMT INVT OFFICES, OPEN-END sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AVNTAvant Brands Inc
      $ 0.96
      (43.28%)
      		37.99k
      IVQ.UInvesque Inc
      $ 0.09
      (20.00%)
      		117.77k
      CNTCentury Global Commodities Corporation
      $ 0.03
      (20.00%)
      		2k
      ATZAritzia Inc
      $ 67.86
      (19.07%)
      		2.05M
      APLIAppili Therapeutics Inc
      $ 0.035
      (16.67%)
      		2k
      OPTOptiva Inc
      $ 3.89
      (-21.57%)
      		2.46k
      FLNTFlint Corporation
      $ 0.025
      (-16.67%)
      		330k
      WMWallbridge Mining Company Limited
      $ 0.06
      (-14.29%)
      		322.2k
      AVLAvalon Advanced Materials Inc
      $ 0.035
      (-12.50%)
      		458.7k
      BSXBelo Sun Mining Corp
      $ 0.075
      (-11.76%)
      		373.65k
      TDToronto Dominion Bank
      $ 78.20
      (0.28%)
      		20.88M
      CNQCanadian Natural Resources Ltd
      $ 47.27
      (0.77%)
      		12.18M
      SUSuncor Energy Inc
      $ 56.81
      (2.95%)
      		10.52M
      BTEBaytex Energy Corp
      $ 3.93
      (2.34%)
      		8.98M
      CVECenovus Energy Inc
      $ 22.24
      (0.72%)
      		8.52M

      Discussion

      View Full Feed
      sunspotter sunspotter 9 minutes ago
      Dr. Jamil should know that once it is established that the primary endpoint has not been reached, it is widely recognised that it is not valid statistically to declare secondary endpoints and other sub-analyses as having reached statistical significance.

      It’s a (not very) sophisticat
      GALT
      nowwhat2 nowwhat2 15 minutes ago
      The Overhead Trendline, The 2.50 Level, The Overall Crypto Sector......

      Boy.......what ppl steer clear of considering here is a real mindblower.......


      https://investorshub.advfn.com/uimage/uploads/2025/1/13/rmobiXRP_!_12_45d_6pm_GLITCH_OHTL_250_SUMMARY.jpg
      XRPUSD
      PickStocks PickStocks 17 minutes ago
      You contradict yourself......" style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"IF YOU owned P's, K's, or uq's ? ... the DTC Knows It' ... and, the DTC Knows EXACTLY How Many P's, K's, or uq's ... YO
      COOP
      Malolo Malolo 18 minutes ago
      Hello, I'm a newbie at AIM. Wondering if someone could recommend or provide a good spreadsheet?
      roncderu@gmail.com.
      OPennyS OPennyS 21 minutes ago
      If the predictions are correct it is going to be an interesting week.
      VXX
      Hoghead7 Hoghead7 23 minutes ago
      PORTHOS still on schedule. Seems like spring/summer commissioning
      https://www.linkedin.com/posts/porthos-co2_porthos-porthosco-co2-activity-7282763014376677376-qnb-?utm_source=share&utm_medium=member_android

      https://www.linkedin.com/posts/activity-7275803191202447360-EX6x?utm
      FCEL
      mining hound mining hound 32 minutes ago
      Hi all, thanks for happy new year wishes and I wish the same for all here too!
      HLLXF
      gfp927z gfp927z 41 minutes ago
      >>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
      ABT
      gfp927z gfp927z 41 minutes ago
      >>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
      ABT
      georgebailey georgebailey 42 minutes ago
      Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
      NWBO
      Birdbrain Ideas Birdbrain Ideas 43 minutes ago
      If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
      AMRN
      devil dog 96 devil dog 96 45 minutes ago
      In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

      If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
      ATMH
      3jack 3jack 45 minutes ago
      We will persevere!
      AVXL
      gfp927z gfp927z 46 minutes ago
      >>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
      ISRG
      3jack 3jack 46 minutes ago
      We know who you are!
      AVXL
      gfp927z gfp927z 46 minutes ago
      >>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
      ISRG
      Lazerator Lazerator 48 minutes ago
      Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
      Lazerator Lazerator 49 minutes ago
      Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
      imho imho 50 minutes ago
      In the comment section of this article,
      https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

      Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

      I asked ChatGPT why the following statement, w
      AVXL
      Ryoko Ryoko 51 minutes ago
      It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
      IBGR
      axelvento axelvento 54 minutes ago
      has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

      $PFE
      PFE
      Steady_T Steady_T 56 minutes ago
      You might be correct about the size of the GBM market in the UK. However you are missing the point.

      Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

      Approval
      NWBO
      skitahoe skitahoe 57 minutes ago
      While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
      NWBO
      Saving Grace Saving Grace 57 minutes ago
      Putz: We are not at 2 years. Who's we? LoL SMH

      Keep an eye on the door. Big revelation! It's coming. UK
      NB

      Your Recent History

      TSX
      AIM.PR.A
      Aimia
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads